ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

VS vs HCTI // EV/EBITDA & P/E VALUATION

Versus Systems Inc. (NASDAQ) VS. Healthcare Triangle Inc. (NASDAQ) • 15-METRIC TALLY: VS 4 — HCTI 1
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (VS VS. HCTI) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC VS HCTI SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 96.00% 96.00% 0.00 TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -17.70% -35.00% +17.30 VS /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — — — TIE /valuation <GO>
Free Cash Flow Yield — — — TIE /fcf-yield <GO>
Operating Margin -60.00% -60.00% 0.00 TIE /operating-margins <GO>
Net Profit Margin -60.00% -60.00% 0.00 TIE /net-margins <GO>
Revenue Growth (YoY) 180.00% 18.80% +161.20 VS /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity — 0.20 — TIE /balance-sheet <GO>
Piotroski F-Score Quality 4/9 3/9 +1.00 VS /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 25.5 24.9 +0.57 VS /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $5.3M $5.6M -$304.2K HCTI /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR VS REV HCTI REV VS GROSS % HCTI GROSS % VS FCF HCTI FCF
FY 2025 $2.2M $13.9M 98.0% 98.0% -$2.1M -$16.5M
FY 2024 $57.3K $11.7M 29.7% 98.0% -$5.0M -$1.1M
FY 2023 $271.2K $33.2M — — -$5.6M -$2.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
VS // BETA —
HCTI // BETA —